Indivior Pharmaceuticals, Inc 6-K, filed Jul 12, 2024
Indivior Pharmaceuticals, Inc. (INDV)
6-K
2024-07-12
For: 2024-07-12
View Original
Added on
April 10, 2026
About this 6-K
Indivior Pharmaceuticals, Inc filed this 6-K on July 12, 2024.
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
________________________
Washington, D.C. 20549
_____________________
FORM 6-K
_____________________
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of July 2024
Commission File Number: 001-37835
________________________________________
Indivior PLC
________________________________________
10710 Midlothian Turnpike, Suite 125
North Chesterfield, Virginia 23235
(Address of principal executive office)
_______________________________
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F
Form
20-F ☒ Form 40-F ☐
|
|
EXHIBIT INDEX
|
Exhibit
No.
|
Description
of Exhibit
|
|
99.1
|
|
|
|
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
Indivior PLC
|
|
Date: July 12,
2024
|
/s/
Kathryn Hudson
|
|
|
Name:
Kathryn Hudson
|
|
|
Title:
Company Secretary
|
|
Exhibit
99.1
|
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
|
GB00BN4HT335
|
Issuer Name
|
INDIVIOR PLC
|
UK or Non-UK Issuer
|
UK
|
2. Reason for Notification
|
An acquisition or disposal of voting rights
|
3. Details of person subject to the notification
obligation
Name
|
Oaktree Capital Management (UK) LLP
|
City of registered office (if applicable)
|
London
|
Country of registered office (if applicable)
|
United Kingdom
|
4. Details of the shareholder
|
Name
|
City
of registered office
|
Country
of registered office
|
|
Oaktree
London Liquid Value Opportunities Fund (VOF), L.P.
|
Los
Angeles
|
United
States of America
|
|
Oaktree
Value Opportunities Fund, L.P.
|
Los
Angeles
|
United
States of America
|
|
Boston
Patriot Arlington St LLC
|
Boston
|
United
States of America
|
|
Oaktree
Phoenix Investment Fund, L.P.
|
Los
Angeles
|
United
States of America
|
5. Date on which the threshold was crossed or reached
|
09-Jul-2024
|
6. Date on which Issuer notified
|
11-Jul-2024
|
7. Total positions of person(s) subject to the notification
obligation
|
|
% of voting rights attached to shares (total of 8.A)
|
% of voting rights through financial instruments (total of 8.B 1 +
8.B 2)
|
Total of both in % (8.A + 8.B)
|
Total number of voting rights held in issuer
|
|
Resulting
situation on the date on which threshold was crossed or
reached
|
6.340000
|
0.000000
|
6.340000
|
8493173
|
|
Position
of previous notification (if applicable)
|
|
|
|
|
8. Notified details of the resulting situation on the date on which
the threshold was crossed or reached
8A. Voting rights attached to shares
|
Class/Type of shares ISIN code(if possible)
|
Number of direct voting rights (DTR5.1)
|
Number of indirect voting rights (DTR5.2.1)
|
% of direct voting rights (DTR5.1)
|
% of indirect voting rights (DTR5.2.1)
|
|
GB00BN4HT335
|
|
8493173
|
|
6.340000
|
|
Sub
Total 8.A
|
8493173
|
6.340000%
|
||
8B1. Financial Instruments according to (DTR5.3.1R.(1)
(a))
|
Type of financial instrument
|
Expiration date
|
Exercise/conversion period
|
Number of voting rights that may be acquired if the instrument is
exercised/converted
|
% of voting rights
|
|
|
|
|
|
|
|
Sub
Total 8.B1
|
|
|
|
|
8B2. Financial Instruments with similar economic effect according
to (DTR5.3.1R.(1) (b))
|
Type of financial instrument
|
Expiration date
|
Exercise/conversion period
|
Physical or cash settlement
|
Number of voting rights
|
% of voting rights
|
|
|
|
|
|
|
|
|
Sub
Total 8.B2
|
|
|
|
||
9. Information in relation to the person subject to the
notification obligation
|
2. Full chain of controlled undertakings through which the voting
rights and/or the financial instruments are effectively held
starting with the ultimate controlling natural person or legal
entities (please add additional rows as necessary)
|
|
Ultimate controlling person
|
Name of controlled undertaking
|
% of voting rights if it equals or is higher than the notifiable
threshold
|
% of voting rights through financial instruments if it equals or is
higher than the notifiable threshold
|
Total of both if it equals or is higher than the notifiable
threshold
|
|
Oaktree
Phoenix Investment Fund, L.P.
|
|
0.200000
|
|
0.200000%
|
|
Boston
Patriot Arlington St LLC
|
|
0.920000
|
|
0.920000%
|
|
Oaktree
Value Opportunities Fund, L.P.
|
|
3.880000
|
|
3.880000%
|
|
Oaktree
London Liquid Value Opportunities Fund (VOF), L.P.
|
|
1.340000
|
|
1.340000%
|
10. In case of proxy voting
Name of the proxy holder
|
|
The number and % of voting rights held
|
|
The date until which the voting rights will be held
|
|
11. Additional Information
|
|
12. Date of Completion
|
11-Jul-2024
|
13. Place Of Completion
|
London
|